Bacterium with Leuconostoc pseudomesenteroides
pdf

Keywords

Leuconostoc pseudomesenteroides
malformație congenitală
bacteriemie
Vancomicin-rezistent
Amoxicilin-clavulanat

How to Cite

IAROVOI, L., HOLBAN, T., CHIRIACOV, G., COTOS, V., COJUHARI, L. and CIRSTEA, N. (2023) “Bacterium with Leuconostoc pseudomesenteroides”, One Health & Risk Management , 4(1), pp. 81-86. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/355 (Accessed: 20June2025).

Abstract

Introduction. Leukonostoc pseudomesenteroides, widespread in nature (soil, plants, milk, etc.), until recently was classified as a commensal microorganism, but from 1985 until now several sporadic cases of infection with this pathogen have been described in humans. Bacteremia with Leuconostoc spp. are increasingly reported. Unique cases of infection of other sites have also been described: in soft, lung, urinary, Central Nervous System tissues, etc. Most often, these cases have been reported in patients with cancer, and are often considered opportunistic for acquired immunodeficiencies. However, several cases have also been reported in immunocompetent patients, including in those previously treated with vancomycin, Leuconostoc spp. having a natural resistance to this antibiotic.

Material and methods. An analysis of the literature and the clinical case are presented here: the child of an 11-month-old with congenital malformation - rabbit lip, who underwent maxillofacial operation twice and had pneumonia 2 months before his admission to the Toma Ciorba Infectious Diseases Clinical Hospital.

Results. Meningococcemia and meningitis were clinically established upon admission. The blood culture result was received a few days later, and Leuconostoc pseudomesenteroides was identified. The etiological treatment was corrected, after which the sterile result of the blood culture was obtained. The child was released in a satisfactory condition.

Conclusions: The clinical case presented is the first case of infection with Leuconstoc spp. described in the Republic of Moldova. The correct choice of the etiological treatment allows the eradication of this pathogen, with a satisfactory clinical result. 

pdf

|Views: 455| |pdf Downloads: 186|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Liviu Iarovoi

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370